Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 19/20 | 0.48 |
| ▸ | CNR2 | P34972 | 11/20 | 0.48 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4826316 | 0.84 | ALDH1A1 (0.54) | CNR1CNR2FDFT1 | |
| SCHEMBL14064681 | 0.84 | ALDH1A1 (0.54) | CNR1CNR2FDFT1 | |
| SCHEMBL14064690 | 0.80 | CNR1 (0.50) | CNR1CNR2 | |
| SCHEMBL4827930 | 0.80 | CNR1 (0.50) | CNR1CNR2 | |
| SCHEMBL13804839 | 0.76 | CNR1 (0.49) | CNR1CNR2FDFT1 | |
| SCHEMBL3527924 | 0.76 | CNR1 (0.49) | CNR1CNR2FDFT1 | |
| SCHEMBL14064724 | 0.75 | CNR1 (0.57) | CNR1CNR2 | |
| SCHEMBL13114020 | 0.75 | CNR1 (0.65) | CNR1CNR2FDFT1 | |
| SCHEMBL4831266 | 0.75 | CNR1 (0.53) | CNR1CNR2FDFT1 | |
| SCHEMBL14064689 | 0.75 | CNR1 (0.53) | CNR1CNR2FDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050239828-A1 | Spirocyclic amides as cannabinoid receptor modulators | MERCK & CO., INC. (US) | 2005-10-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239828-A1 | Spirocyclic amides as cannabinoid receptor modulators | CNR1, CNR2, MAG | CNR1 1/4885CNR2 2/4885FDFT1 3102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.